Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ann Card Anaesth ; 2022 Sep; 25(3): 362-365
Article | IMSEAR | ID: sea-219241

ABSTRACT

The Tempo® Temporary Pacing Lead is a temporary, transvenous, active fixation pacemaker lead used exclusively in structural heart and electrophysiology procedures since regulatory approval in 2016. We utilized the Tempo lead for four patients undergoing redo?robotic cardiac surgery in which surgical epicardial leads could not be placed.No failure?to?pace events were encountered and patients were able to participate in various levels of physical activity without limitation

2.
Rev. bras. cir. cardiovasc ; 34(3): 285-289, Jun. 2019. tab, graf
Article in English | LILACS | ID: biblio-1013466

ABSTRACT

Abstract Introduction: This study aimed to evaluate the feasibility and efficacy of robotically assisted, minimally invasive mitral valve surgery combined with left atrial reduction for mitral valve surgery and elimination of atrial fibrillation (AF). Methods: Eleven patients with severe mitral regurgitation, AF, and left atrial enlargement who underwent robotic, minimally invasive surgery between May 2013 and March 2018 were evaluated retrospectively. The da Vinci robotic system was used in all procedures. The patients' demographic data, electrocardiography (ECG) findings, and pre- and postoperative transthoracic echocardiography findings were analyzed. During follow up ECG was performed at postoperative 3, 6, and 12 months additionally at the 3rd month trans thoracic echocardiography was performed and functional capacity was also evaluated for all patients. Results: All patients underwent robotic-assisted mitral valve surgery with radiofrequency ablation and left atrial reduction. Mean age was 45.76±16.61 years; 7 patients were male and 4 were female. Preoperatively, mean left atrial volume index (LAVI) was 69.55±4.87 mL/m2, ejection fraction (EF) was 54.62±8.27%, and pulmonary artery pressure (PAP) was 45.75±9.42 mmHg. Postoperatively, in hospital evaluation LAVI decreased to 48.01±4.91 mL/m2 (P=0.008), EF to 50.63±10.13% (P>0.05), and PAP to 39.02±3.11 mmHg (P=0.012). AF was eliminated in 8 (72%) of the 11 patients at the 1st postoperative month. There were significant improvements in functional capacity and no mortality during follow-up. Conclusion: Left atrial reduction and radiofrequency ablation concomitant with robotically assisted minimally invasive mitral valve surgery can be performed safely and effectively to eliminate AF and prevent recurrence.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Atrial Fibrillation/surgery , Robotic Surgical Procedures/methods , Radiofrequency Ablation/methods , Heart Atria/surgery , Mitral Valve/surgery , Time Factors , Echocardiography , Reproducibility of Results , Retrospective Studies , Follow-Up Studies , Treatment Outcome , Statistics, Nonparametric
3.
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery ; (12): 1014-1020, 2019.
Article in Chinese | WPRIM | ID: wpr-751029

ABSTRACT

@#Minimally invasive cardiac surgeries are the trend in the future. Among them, robotic cardiac surgery is the latest iteration with several key-hole incision, 3-dimentional visualization, and articulated instrumentation of 7 degree of ergonomic freedom for those complex procedures in the heart. In particular, robotic mitral valve surgery, as well as coronary artery bypass grafting, has evolved over the last decade and become the preferred method at certain specialized centers worldwide because of excellent results. Other cardiac procedures are in various stages of evolution. Stepwise innovation of robotic technology will continue to make robotic operations simpler, more efficient, and less invasive, which will encourage more surgeons to take up this technology and extend the benefits of robotic surgery to a larger patient population.

4.
Ann Card Anaesth ; 2010 May; 13(2): 169-175
Article in English | IMSEAR | ID: sea-139523

ABSTRACT

The surgical procedures performed with robtic assitance and the scope for its future assistance is endless. To keep pace with the developing technologies in this field it is imperative for the cardiac anesthesiologists to have aworking knowledge of these systems, recognize potential complications and formulate an anesthetic plan to provide safe patient care. Challenges posed by the use of robotic systems include, long surgical times, problems with one lung anesthesia in presence of coronary artery disease, minimally invasive percutaneous cardiopulmonary bypass management and expertise in Trans-Esophageal Echocardiography. A long list of cardiac surgeries are performed with the use of robotic assistance, and the list is continuously growing as surgical innovation crosses new boundaries. Current research in robotic cardiac surgery like beating heart off pump intracardic repair, prototype epicardial crawling device, robotic fetal techniques etc. are in the stage of animal experimentation, but holds a lot of promise in future.


Subject(s)
Anesthesia/methods , Cardiac Surgical Procedures/instrumentation , Cardiac Surgical Procedures/methods , Cardiac Surgical Procedures/trends , Catheterization , Humans , Patient Positioning , Patient Selection , Robotics/methods , Robotics/trends , Robotics/statistics & numerical data
5.
Korean Journal of Anesthesiology ; : 371-375, 2007.
Article in Korean | WPRIM | ID: wpr-149350

ABSTRACT

Minimally invasive cardiac surgery including robotic technique has become increasingly popular over the last decade. The advantages of such technique include improved cosmesis and healing, and reduced stress response, hospital and intensive care unit stay, and transfusion requirements. Robot-assisted cardiac surgery requires prolonged one-lung ventilation to optimize exposure. Remote-access perfusion requires appropriate positioning of multiple catheters to establish cardiopulmonary bypass. Carbon dioxide insufflation into the thorax can cause hemodynamic instability and carbon dioxide embolism. Limited exposure of the heart may pose difficulties with management of arrhythmia, hemostasis, myocardial protection and de-airing at the end of surgery. Limited access due to robot manipulator would make rapid intervention for cardiopulmonary resuscitation difficult or impossible. This case report describes robot-asssisted atrial septal defect repair and discusses the anesthetic issues associated with minimally invasive cardiac surgery including robotic cardiac surgery.


Subject(s)
Anesthesia , Arrhythmias, Cardiac , Carbon Dioxide , Cardiopulmonary Bypass , Cardiopulmonary Resuscitation , Catheters , Embolism , Heart , Heart Septal Defects, Atrial , Hemodynamics , Hemostasis , Insufflation , Intensive Care Units , One-Lung Ventilation , Perfusion , Thoracic Surgery , Thorax
SELECTION OF CITATIONS
SEARCH DETAIL